1. Home
  2. CTRE vs PTGX Comparison

CTRE vs PTGX Comparison

Compare CTRE & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$39.05

Market Cap

9.9B

Sector

Real Estate

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$143.86

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
PTGX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
9.5B
IPO Year
2013
2016

Fundamental Metrics

Financial Performance
Metric
CTRE
PTGX
Price
$39.05
$143.86
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$42.40
$108.23
AVG Volume (30 Days)
1.8M
451.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
3.44%
N/A
EPS Growth
96.25
N/A
EPS
0.74
2.35
Revenue
$476,393,000.00
N/A
Revenue This Year
$5.97
$874.25
Revenue Next Year
$13.39
N/A
P/E Ratio
$53.19
$63.62
Revenue Growth
60.79
N/A
52 Week Low
$32.79
$57.45
52 Week High
$43.62
$160.81

Technical Indicators

Market Signals
Indicator
CTRE
PTGX
Relative Strength Index (RSI) 42.48 50.81
Support Level $38.28 $127.98
Resistance Level $40.12 $160.81
Average True Range (ATR) 0.78 5.32
MACD -0.00 -1.38
Stochastic Oscillator 55.06 9.68

Price Performance

Historical Comparison
CTRE
PTGX

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: